Sfoglia per Autore
The etiology of viral cirrhosis affects the survival od patients with hepatocellular carcinoma. A case-control study.
2004 Cantarini M.C.; Trevisani F.; Mirici F.; Rapaccini G.; Farinati F.; Del Poggio P.; Di Nolfo M.A.; Benvegnù L.; Zoli M.; Borzio F.; Bendini C.; Magini G.; Santi V.; Zambruni A.; Caraceni P.; Domenicali M.; Bernardi M.
How should the patients with HCC managed in the waiting list: the hepatologist perspective.
2005 Trevisani F.; Magini G.
Effects of the combined treatment with thalidomide and megestrol in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
2005 Mirici Cappa F.; Cantarini M.C.; Magini G.; Zambruni A.; Bendini C.; Santi V.; Bernardi M.; Trevisani F.
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis
2006 A. Zambruni; F. Savelli; A. Berzigotti; G. Magini; F. Mirici Cappa; M.C. Cantarini; P. Caraceni; M. Domenicali; A. Di Micoli; F. Felline; S. Lorenzini; M. Zoli; M. Bernardi; F. Trevisani
Impact of etiology of cirrhosis on HCC stage and on survival of patients under surveillance
2006 G. Magini; V. Santi; A.M. Morselli Labate; F. Farinati; L. Benvegnù; M. Zoli; P. Del Poggio; M.A. Di Nolfo; F. Borzio; E. Giannini; E. Caturelli; G. Rapaccini; M. Bernardi; F. Trevisani for ITA.LI.CA (Italian Liver cancer) group.
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis
2006 A. Zambruni; F. Savelli; A. Berzigotti; G. Magini; F. Mirici Cappa; M.C. Cantarini; P. Caraceni; M. Domenicali; A. Di Micoli; F. Felline; S. Lorenzini; M. Zoli; M. Bernardi; F. Trevisani
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function.
2007 Zambruni A; Trevisani F; Gülberg V; Caraceni P; Domenicali M; Cantarini MC; Mirici Cappa F; Di Micoli A; Magini G; Morselli-Labate AM; Gerbes AI; Bernardi M.
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
2007 Franco Trevisani; Giulia Magini; Valentina Santi; Antonio Maria Morselli-Labate; Maria Chiara Cantarini; Maria Anna Di Nolfo; Paolo Del Poggio; Luisa Benvegnù; Gianludovico Rapaccini; Fabio Farinati; Marco Zoli; Franco Borzio; Edoardo Giovanni Giannini; Eugenio Caturelli; Mauro Bernardi; for the Italian Liver Cancer (ITA.LI.CA) Group; Pietro Andreone; Maurizio Biselli; Paolo Caraceni; Maria Chiara Cantarini; Carmela Cursaro; Marco Domenicali; Annagiulia Gramenzi; Silvia Li Bassi; Donatella Magalotti; Federica Mirici Cappa; Andrea Zambruni; Gian Luca Grazi; Bruno Nardo; Matteo Ravaioli; Cristina Rossi; Rita Golfieri
Telangiectasia as a presenting sign of Graves’ disease.
2008 Casadio R; Santi V; Mirici Cappa F; Magini G; Cacciari M; Bernardi M; Trevisani F.
Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG
2008 Magini G, Frigerio M, Farsad M, Serra C, Colecchia A, Jovine E, Vivarelli M, Feletti V, Golfieri R, Lodi F, Franchi R, Fanti S, Bernardi M, Trevisani F
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
2009 Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F.
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders
2021 Ielasi L.; Tovoli F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Sansone V.; Marasco G.; Piscaglia F.; Granito A.
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy
2024 Ielasi L.; Stefanini B.; Conti F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Foschi F.G.; Piscaglia F.; Granito A.; Tovoli F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| The etiology of viral cirrhosis affects the survival od patients with hepatocellular carcinoma. A case-control study. | Cantarini M.C.; Trevisani F.; Mirici F.; Rapaccini G.; Farinati F.; Del Poggio P.; Di Nolfo M.A.;... Benvegnù L.; Zoli M.; Borzio F.; Bendini C.; Magini G.; Santi V.; Zambruni A.; Caraceni P.; Domenicali M.; Bernardi M. | 2004-01-01 | HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| How should the patients with HCC managed in the waiting list: the hepatologist perspective. | Trevisani F.; Magini G. | 2005-01-01 | - | PTV Azienda Ospedaliera Universitaria | 4.01 Contributo in Atti di convegno | - |
| Effects of the combined treatment with thalidomide and megestrol in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study. | Mirici Cappa F.; Cantarini M.C.; Magini G.; Zambruni A.; Bendini C.; Santi V.; Bernardi M.; Trevi...sani F. | 2005-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis | A. Zambruni; F. Savelli; A. Berzigotti; G. Magini; F. Mirici Cappa; M.C. Cantarini; P. Caraceni; ...M. Domenicali; A. Di Micoli; F. Felline; S. Lorenzini; M. Zoli; M. Bernardi; F. Trevisani | 2006-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| Impact of etiology of cirrhosis on HCC stage and on survival of patients under surveillance | G. Magini; V. Santi; A.M. Morselli Labate; F. Farinati; L. Benvegnù; M. Zoli; P. Del Poggio; M.A.... Di Nolfo; F. Borzio; E. Giannini; E. Caturelli; G. Rapaccini; M. Bernardi; F. Trevisani for ITA.LI.CA (Italian Liver cancer) group. | 2006-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis | A. Zambruni; F. Savelli; A. Berzigotti; G. Magini; F. Mirici Cappa; M.C. Cantarini; P. Caraceni; ...M. Domenicali; A. Di Micoli; F. Felline; S. Lorenzini; M. Zoli; M. Bernardi; F. Trevisani | 2006-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. | Zambruni A; Trevisani F; Gülberg V; Caraceni P; Domenicali M; Cantarini MC; Mirici Cappa F; Di Mi...coli A; Magini G; Morselli-Labate AM; Gerbes AI; Bernardi M. | 2007-01-01 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. | Franco Trevisani; Giulia Magini; Valentina Santi; Antonio Maria Morselli-Labate; Maria Chiara Can...tarini; Maria Anna Di Nolfo; Paolo Del Poggio; Luisa Benvegnù; Gianludovico Rapaccini; Fabio Farinati; Marco Zoli; Franco Borzio; Edoardo Giovanni Giannini; Eugenio Caturelli; Mauro Bernardi; for the Italian Liver Cancer (ITA.LI.CA) Group; Pietro Andreone; Maurizio Biselli; Paolo Caraceni; Maria Chiara Cantarini; Carmela Cursaro; Marco Domenicali; Annagiulia Gramenzi; Silvia Li Bassi; Donatella Magalotti; Federica Mirici Cappa; Andrea Zambruni; Gian Luca Grazi; Bruno Nardo; Matteo Ravaioli; Cristina Rossi; Rita Golfieri | 2007-01-01 | THE AMERICAN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Telangiectasia as a presenting sign of Graves’ disease. | Casadio R; Santi V; Mirici Cappa F; Magini G; Cacciari M; Bernardi M; Trevisani F. | 2008-01-01 | HORMONE RESEARCH | - | 1.01 Articolo in rivista | - |
| Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG | Magini G, Frigerio M, Farsad M, Serra C, Colecchia A, Jovine E, Vivarelli M, Feletti V, Golfieri ...R, Lodi F, Franchi R, Fanti S, Bernardi M, Trevisani F | 2008-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. | Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri ...R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F. | 2009-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders | Ielasi L.; Tovoli F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Sa...nsone V.; Marasco G.; Piscaglia F.; Granito A. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-06376.pdf |
| Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy | Ielasi L.; Stefanini B.; Conti F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Tre...visani F.; Foschi F.G.; Piscaglia F.; Granito A.; Tovoli F. | 2024-01-01 | CURRENT ONCOLOGY | - | 1.01 Articolo in rivista | curroncol-31-00038.pdf; curroncol-31-00038-s001.zip |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile